Long-term follow-up of COVID-19 patients
Long-term Large Sample Multicenter Follow-up Study of COVID-19
Tongji Hospital · NCT05986435
This study is looking at the long-term health and well-being of people who have recovered from COVID-19 to see what complications they might still face.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5700 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Tongji Hospital (other) |
| Locations | 2 sites (Wuhan, Hu Bei Province and 1 other locations) |
| Trial ID | NCT05986435 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the long-term prognosis and clinical characteristics of complications in patients who have recovered from COVID-19. It will include 5700 inpatients with confirmed positive SARS CoV-2 nucleic acid tests, monitoring their health and psychological status over time. Clinical samples such as blood, urine, and feces will be collected at various intervals post-discharge to evaluate ongoing health issues and quality of life. The study will also document treatment regimens and various health metrics to better understand the long-term effects of COVID-19.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have been hospitalized and confirmed to have COVID-19.
Not a fit: Patients with combined infections from influenza virus, mycoplasma, or chlamydia may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term health impacts of COVID-19, guiding future treatment and management strategies.
How similar studies have performed: Other studies have explored the long-term effects of COVID-19, indicating a growing body of evidence on this topic, though this specific approach may offer novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with confirmed COVID-19 Exclusion Criteria: * Combined infection with influenza virus, mycoplasma, and chlamydia.
Where this trial is running
Wuhan, Hu Bei Province and 1 other locations
- Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology — Wuhan, Hu Bei Province, China (RECRUITING)
- Wuhan Seventh Hospital — Wuhan, Hu Bei Province, China (RECRUITING)
Study contacts
- Principal investigator: Qin Ning, Professor — Tongji Hospital
- Study coordinator: Qin Ning, Professor
- Email: qning@vip.sina.com
- Phone: +8613971521450
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: COVID-19